Testing effectiveness (Phase 2)Study completedNCT01619969What this trial is testingCelgosivir as a Treatment Against DengueWho this might be right forDengue Fever Singapore General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00730288What this trial is testingStudy of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsWho this might be right forDengueDengue FeverDengue Hemorrhagic Fever+1 more Sanofi 35
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Not applicableStudy completedNCT04514107What this trial is testingA Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)Who this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 5,757
Not applicableStudy completedNCT03641339What this trial is testingDefining Skin Immunity of a Bite of Key Insect Vectors in HumansWho this might be right forZikaDengueMalaria+2 more National Institute of Allergy and Infectious Diseases (NIAID) 95
Early research (Phase 1)Study completedNCT02887482What this trial is testingGLS-5700 in Dengue Virus Seropositive AdultsWho this might be right forHealthyZika GeneOne Life Science, Inc. 160
Early research (Phase 1)Study completedNCT00920517What this trial is testingSafety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Looking for participantsNCT07576868What this trial is testingCP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)Who this might be right forDengue Hyundai Bioscience Co., Ltd. 210
Early research (Phase 1)Study completedNCT04786457What this trial is testingADVP005; Dengue CVD 12000 - Dengue-1-Virus Live Virus Human Challenge (DENV-1-LVHC)Who this might be right forDengue University of Maryland, Baltimore 10
Testing effectiveness (Phase 2)Study completedNCT02193087What this trial is testingSafety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)Who this might be right forDengue Fever Takeda 1,002
Early research (Phase 1)Study completedNCT00089908What this trial is testingSafety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy AdultsWho this might be right forDengue Fever National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT02628444What this trial is testingImmunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeWho this might be right forDengue FeverDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 1,050
Not applicableStudy completedNCT02741882What this trial is testingZika and Microcephaly: Case-control StudyWho this might be right forMicrocephaly Laboratório Sabin 110
Early research (Phase 1)Study completedNCT03869060What this trial is testingExpansion of a Dengue-1 Live Virus Human ChallengeWho this might be right forDengue State University of New York - Upstate Medical University 9
Not applicableLooking for participantsNCT07602920What this trial is testingGut Leakage' in DengueWho this might be right forDengueDengue Hemorrhagic FeverIntestinal Disease+3 more University of Oxford 190
Not applicableStudy completedNCT06648603What this trial is testingCitizen Action for Sustainable Dengue Control in Sub-Saharan AfricaWho this might be right forDengue Swiss Tropical & Public Health Institute 40
Testing effectiveness (Phase 2)Study completedNCT02948829What this trial is testingSafety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenWho this might be right forHealthy Volunteers Takeda 200
Testing effectiveness (Phase 2)Ended earlyNCT05201794What this trial is testingJNJ-64281802 for the Prevention of Dengue InfectionWho this might be right forDengue Janssen Research & Development, LLC 1,595
Large-scale testing (Phase 3)Study completedNCT03341637What this trial is testingImmunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)Who this might be right forDengue Takeda 400
Early research (Phase 1)Study completedNCT01110551What this trial is testingTetravalent Chimeric Dengue Vaccine TrialWho this might be right forDengue National Institute of Allergy and Infectious Diseases (NIAID) 72